Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Design and Evaluation of Novel Antimicrobial and Anticancer Agents Among Tetrazolo[1,5-c]quinazoline-5-thione S-Derivatives.

Antypenko LM, Kovalenko SI, Antypenko OM, Katsev AM, Achkasova OM.

Sci Pharm. 2013 Jan-Mar;81(1):15-42. doi: 10.3797/scipharm.1208-13. Epub 2012 Oct 9.

2.

2-alkyl(aryl)-quinazolin-4(3H)-thiones, 2-R-(quinazolin-4(3H)-ylthio)carboxylic acids and amides: synthesis, molecular docking, antimicrobial and anticancer properties.

Antypenko L, Kovalenko S, Posylkina Y, Nikitin V, Fedyunina N, Ivchuk V.

J Enzyme Inhib Med Chem. 2016;31(2):253-65. doi: 10.3109/14756366.2015.1018243. Epub 2015 Apr 1.

PMID:
25831026
3.

1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: synthesis, bioluminescence inhibition, molecular docking studies, antibacterial and antifungal activity.

Antypenko LM, Kovalenko SI, Karpenko OV, Katsev AM, Novikov VP, Fedyunina NS.

Curr Comput Aided Drug Des. 2016 Jan 26. [Epub ahead of print]

PMID:
26813534
4.

Synthesis of 6-N-R-Tetrazolo[1,5-c]quinazolin-5(6H)-ones and Their Anticancer Activity.

Antypenko O, Kovalenko S, Rasulev B, Leszczynski J.

Acta Chim Slov. 2016;63(3):638-45.

PMID:
27640391
5.

Synthesis, cytotoxicity by bioluminescence inhibition, antibacterial and antifungal activity of ([1,2,4]Triazolo[1,5-c]quinazolin-2-ylthio)carboxylic acid amides.

Antipenko LN, Karpenko AV, Kovalenko SI, Katsev AM, Komarovska-Porokhnyavets EZ, Novikov VP.

Arch Pharm (Weinheim). 2009 Nov;342(11):651-62. doi: 10.1002/ardp.200900077.

PMID:
19882690
6.

Synthesis of New 6-{[ω-(Dialkylamino(heterocyclyl)alkyl]thio}-3-R-2H-[1,2,4]triazino[2,3-c]quinazoline-2-ones and Evaluation of their Anticancer and Antimicrobial Activities.

Berest GG, Voskoboynik OY, Kovalenko SI, Nosulenko IS, Antypenko LM, Antypenko OM, Shvets VM, Katsev AM.

Sci Pharm. 2012 Jan-Mar;80(1):37-65. doi: 10.3797/scipharm.1111-15. Epub 2011 Dec 23.

7.

Synthesis of new 2-thio-[1,2,4]triazolo[1,5-c]quinazoline derivatives and its antimicrobial activity.

Antipenko L, Karpenko A, Kovalenko S, Katsev A, Komarovska-Porokhnyavets E, Novikov V, Chekotilo A.

Chem Pharm Bull (Tokyo). 2009 Jun;57(6):580-5.

8.

1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities.

Antypenko LM, Kovalenko SI, Karpenko OV, Katsev AM, Novikov VP, Fedyunina NS.

Curr Comput Aided Drug Des. 2016;12(1):29-41.

PMID:
27012316
9.

Synthesis and Antimicrobial Activity of 6-Thioxo-6,7-dihydro-2H-[1,2,4]triazino[2,3-c]-quinazolin-2-one Derivatives.

Nosulenko IS, Voskoboynik OY, Berest GG, Safronyuk SL, Kovalenko SI, Kamyshnyi OM, Polishchuk NM, Sinyak RS, Katsev AV.

Sci Pharm. 2014 Mar 24;82(3):483-500. doi: 10.3797/scipharm.1402-10. Print 2014 Jul-Sep.

10.

Indolylmethylene benzo[h]thiazolo[2,3-b]quinazolinones: synthesis, characterization and evaluation of anticancer and antimicrobial activities.

Gali R, Banothu J, Porika M, Velpula R, Hnamte S, Bavantula R, Abbagani S, Busi S.

Bioorg Med Chem Lett. 2014 Sep 1;24(17):4239-42. doi: 10.1016/j.bmcl.2014.07.030. Epub 2014 Jul 17.

PMID:
25096298
11.

Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.

Berest GG, Voskoboynik OY, Kovalenko SI, Antypenko OM, Nosulenko IS, Katsev AM, Shandrovskaya OS.

Eur J Med Chem. 2011 Dec;46(12):6066-74. doi: 10.1016/j.ejmech.2011.10.022. Epub 2011 Oct 20.

PMID:
22051065
12.

Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)-[1,2,4]triazolo[1,5-c]quinazolines.

Kovalenko SI, Antypenko LM, Bilyi AK, Kholodnyak SV, Karpenko OV, Antypenko OM, Mykhaylova NS, Los TI, Kolomoets OS.

Sci Pharm. 2013 Apr-Jun;81(2):359-91. doi: 10.3797/scipharm.1211-08. Epub 2012 Dec 23.

13.

Search for Compounds with Hypoglycemic Activity in the Series of 1-[2-(1H-Tetrazol-5-yl)-R(1)-phenyl]-3-R(2)-phenyl(ethyl)ureas and R(1)-Tetrazolo[1,5-c]quinazolin-5(6H)-ones.

Antypenko OM, Kovalenko SI, Zhernova GO.

Sci Pharm. 2016 Apr-Jun;84(2):233-54. doi: 10.3797/scipharm.1507-14. Epub 2015 Oct 10.

14.

Substituted 2-[(2-Oxo-2H-[1,2,4]triazino [2,3-c]quinazolin-6-yl)thio]acetamides with Thiazole and Thiadiazole Fragments: Synthesis, Physicochemical Properties, Cytotoxicity, and Anticancer Activity.

Kovalenko SI, Nosulenko IS, Voskoboynik AY, Berest GG, Antypenko LN, Antypenko AN, Katsev AM.

Sci Pharm. 2012 Oct-Dec;80(4):837-65. doi: 10.3797/scipharm.1208-07. Epub 2012 Oct 4.

15.

Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.

Gibson MZ, Nguyen MA, Zingales SK.

Med Chem. 2017 Oct 20. doi: 10.2174/1573406413666171020121244. [Epub ahead of print]

PMID:
29065840
16.

Synthesis, in vitro antibacterial and antifungal evaluations of new alpha-hydroxyphosphonate and new alpha-acetoxyphosphonate derivatives of tetrazolo [1, 5-a] quinoline.

Kategaonkar AH, Pokalwar RU, Sonar SS, Gawali VU, Shingate BB, Shingare MS.

Eur J Med Chem. 2010 Mar;45(3):1128-32. doi: 10.1016/j.ejmech.2009.12.013. Epub 2009 Dec 24.

PMID:
20036039
17.

Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.

Bozorov K, Ma HR, Zhao JY, Zhao HQ, Chen H, Bobakulov K, Xin XL, Elmuradov B, Shakhidoyatov K, Aisa HA.

Eur J Med Chem. 2014 Sep 12;84:739-45. doi: 10.1016/j.ejmech.2014.07.065. Epub 2014 Jul 21.

PMID:
25064350
18.

Report: synthesis and evaluation of mannich bases of Benzimidazo [1,2-c] quinazolin- 6(5h)-thione for antimicrobial activity.

Saraswathi M, Rohini RM, Ranaprathapsingh, Nayeem N.

Pak J Pharm Sci. 2010 Oct;23(4):459-62.

PMID:
20884463
19.
20.

Supplemental Content

Support Center